side effects of glp-1 receptor agonists Your guide to GLP-1 side effects GLP1 Receptor Agonists—Effects beyond Obesity
Description
Why it matters: Cigna joins a growing list of employers and insurers scaling back GLP-1 weight loss drug coverage as prescriptions surge
F., Ciudin, A., Yokote, K., Halpern, B., Shukla, A
marketed as Mounjaro for T2DM and Zepbound for obesity), is a 39-amino acid peptide acylated with a C20:0 fatty diacid moiety to lysine residue at position 20 with a molecular weight of 4.8 kDa [ Figure 2 , Table 1 ]
Hisadome K, Reimann F, Gribble FM, Trapp S
The study was funded, in part, by the National Institutes of Health (grants P30 AI036214, R01DK121619 and UM1TR004528) and the James B
